MyAverix Finance
HK · Healthcare
WuXi Biologics (2269)
Biotechnology
WuXi Biologics (2269) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $136.99B, P/E ratio is 24.73, net margin is 22.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2269
WuXi Biologics (2269) — FAQ
What is WuXi Biologics's market cap?
WuXi Biologics (2269) has a reported market cap of $136.99B (data as of 2026-05-21).
What is 2269's P/E ratio?
The price-to-earnings (P/E) ratio for WuXi Biologics (2269) is 24.73 (data as of 2026-05-21).
Does WuXi Biologics pay a dividend?
Dividend yield is not available in the current snapshot for WuXi Biologics (2269). Check the MyAverix Finance app for the latest dividend data.
What sector is WuXi Biologics in?
WuXi Biologics (2269) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 2269 listed on?
2269 is listed on HK.
What is WuXi Biologics's net margin?
WuXi Biologics (2269) reports a net margin of 22.5% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.